LivaNova PLC
LIVN
$39.18
$0.621.61%
Weiss Ratings | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.12 | |||
Price History | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.14% | |||
30-Day Total Return | -22.63% | |||
60-Day Total Return | -23.92% | |||
90-Day Total Return | -24.10% | |||
Year to Date Total Return | -16.01% | |||
1-Year Total Return | -23.36% | |||
2-Year Total Return | -5.68% | |||
3-Year Total Return | -46.92% | |||
5-Year Total Return | -13.13% | |||
52-Week High % Change | -40.19% | |||
52-Week Low % Change | 4.64% | |||
Price | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $64.48 | |||
52-Week Low Price | $36.85 | |||
52-Week Low Price (Date) | Mar 10, 2025 | |||
52-Week High Price (Date) | May 06, 2024 | |||
Valuation | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 2.10B | |||
Enterprise Value | 2.34B | |||
Price/Earnings (TTM) | 33.61 | |||
Earnings Per Share (TTM) | 1.15 | |||
Earnings Per Share Growth | 261.84% | |||
Price/Earnings To Growth | 0.13 | |||
Price/Sales (TTM) | 1.68 | |||
Price/Book (Q) | 1.59 | |||
Enterprise Value/Revenue (TTM) | 1.87 | |||
Price | $39.18 | |||
Enterprise Value/EBITDA (TTM) | 11.76 | |||
Enterprise Value/EBIT | 14.93 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 54.70M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 44 20 3325 0660 | |||
Address | -- | |||
Website | www.livanova.com | |||
Country | United Kingdom | |||
Year Founded | 2015 | |||
Profitability | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 12.52% | |||
Profit Margin | 5.04% | |||
Management Effectiveness | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.98% | |||
Return on Equity | 4.87% | |||
Income Statement | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.25B | |||
Total Revenue (TTM) | 1.25B | |||
Revenue Per Share | $22.91 | |||
Gross Profit (TTM) | 872.17M | |||
EBITDA (TTM) | 199.33M | |||
EBIT (TTM) | 157.01M | |||
Net Income (TTM) | 63.23M | |||
Net Income Avl. to Common (TTM) | 63.23M | |||
Total Revenue Growth (Q YOY) | 3.77% | |||
Earnings Growth (Q YOY) | 242.07% | |||
EPS Diluted (TTM) | 1.15 | |||
EPS Diluted Growth (Q YOY) | 242.92% | |||
Balance Sheet | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 428.86M | |||
Cash Per Share (Q) | $7.84 | |||
Total Current Assets (Q) | 1.13B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.32B | |||
Current Ratio (Q) | 2.875 | |||
Book Value Per Share (Q) | $24.29 | |||
Total Assets (Q) | 2.51B | |||
Total Current Liabilities (Q) | 392.13M | |||
Total Debt (Q) | 676.77M | |||
Total Liabilities (Q) | 1.19B | |||
Total Common Equity (Q) | 1.32B | |||
Cash Flow | LIVN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -48.16M | |||
Cash from Financing (TTM) | 18.55M | |||
Net Change in Cash (TTM) | 145.68M | |||
Levered Free Cash Flow (TTM) | 124.80M | |||
Cash from Operations (TTM) | 183.04M | |||